Identification of Anti-Trypanosoma cruzi Lead Compounds with Putative Immunomodulatory Activity

In seeking substitutions for the current Chagas disease treatment, which has several relevant side effects, new therapeutic candidates have been extensively investigated. In this context, a balanced interaction between mediators of the host immune response seems to be a key element for therapeutic s...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Antimicrob Agents Chemother
Główni autorzy: Otta, Dayane Andriotti, de Araújo, Fernanda Fortes, de Rezende, Vitor Bortolo, Souza-Fagundes, Elaine Maria, Elói-Santos, Silvana Maria, Costa-Silva, Matheus Fernandes, Santos, Raiany Araújo, Costa, Heloísa Alves, Siqueira-Neto, Jair Lage, Martins-Filho, Olindo Assis, Teixeira-Carvalho, Andréa
Format: Artigo
Język:Inglês
Wydane: American Society for Microbiology 2018
Hasła przedmiotowe:
Experimental Therapeutics
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5913944/
https://ncbi.nlm.nih.gov/pubmed/29437629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01834-17
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy